WVE
Wave Life Sciences Ltd.
NASDAQ · Healthcare · Biotechnology · SG
$3.65
+2.00%Next report
Analyst consensus
- Next report date
- Feb 25, 2027
- EPS estimate
- -$0.34
- Revenue estimate
- $10.4M
Latest reported
- Last report date
- Oct 27, 2026
- EPS actual
- -$0.30
- EPS estimate
- -$0.33
- Revenue actual
- $13.2M
- Revenue estimate
- $4.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +12.6%
- Revenue beats (12Q)
- 6
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $24
- PT range
- $10 – $44
- Analysts
- 6
5 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 27, 2026 | -$0.33 | -$0.30 | Beat 8.83% | $13.2M |
| Jul 30, 2026 | -$0.30 | -$0.34 | Miss -13.43% | $2.3M |
| Apr 28, 2026 | -$0.34 | -$0.13 | Beat 61.76% | $38.2M |
| Jul 30, 2025 | -$0.29 | -$0.31 | Miss -6.90% | $8.7M |
| May 8, 2025 | -$0.27 | -$0.29 | Miss -7.41% | $9.2M |
| Mar 4, 2025 | -$0.17 | $0.17 | Beat 200.00% | $83.7M |
| May 9, 2024 | -$0.18 | -$0.24 | Miss -33.33% | $12.5M |
| Mar 6, 2024 | -$0.19 | -$0.15 | Beat 21.05% | $29.1M |
| Nov 9, 2023 | -$0.18 | $0.07 | Beat 138.89% | $49.2M |
| Aug 3, 2023 | -$0.32 | -$0.20 | Beat 37.50% | $22.1M |
| May 3, 2023 | $0.06 | -$0.27 | Miss -550.00% | $12.9M |
| Mar 22, 2023 | -$0.42 | -$0.47 | Miss -11.90% | $1.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 25, 2027